Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 80Neoplasm Metastasis 6Neoplasms 3Breast Neoplasms, Male 3Arthralgia 2Triple Negative Breast Neoplasms 1Sleep Wake Disorders 1Skin Diseases 1Prostatic Neoplasms 1Post Menopausal Women With Early Breast Cancer 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Obesity 1Metastatic Beast Cancer 1Mammary Neoplasms, Animal 1Lymphoma 1Lethal Congenital Contracture Syndrome 2 1Invasive Early Breast Cancer 1Human Epidermal Growth Factor 2 Negative Carcinoma of Breast 1Fatigue 1Estrogen-receptor Positive Invasive Metastatic Breast Cancer 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Breast Diseases 1Breast Carcinoma In Situ 1Breast Cancer Metastatic 1Advanced Breast Carcinoma 1

Interventions

Tamoxifen 6Radiotherapy 3Anastrozole 3Taxes 2Simvastatin 2Radiation 2Paclitaxel 2Neoadjuvant Therapy 2Letrozole 2Gene Expression Profiling 2Chemotherapy, Adjuvant 2Celecoxib 2telapristone acetate 1poly(I).poly(c12,U) 1oxybutynin 1liposomal doxorubicin 1exemestane 1dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Yoga 1Sugars 1Sentinel Lymph Node Biopsy 1Ranitidine 1Radiation Dose Hypofractionation 1Pharmacogenomic Testing 1Naltrexone 1Monitoring, Physiologic 1Mometasone Furoate 1Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Breast Carcinoma In Situ × exemestane × Clear all
NCT02598557 2023-08-22

Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer

National Cancer Institute (NCI)

Phase 2 Completed
180 enrolled 46 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡